Back
Day Range
$61.56
$63.17
52-Week Range
$57.25
$89.37
Volume
414,667
50D / 200D Avg
$65.70
/
$67.08
Prev Close
$60.99
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (625 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 14.1 | 14.0 |
| P/B | 1.7 | 2.4 |
| ROE % | 12.3 | 11.4 |
| Net Margin % | 18.9 | 10.1 |
| Rev Growth 5Y % | 4.8 | 7.0 |
| D/E | 0.6 | 0.5 |
Key Takeaways
Revenue grew 4.80% annually over 5 years — modest growth
ROE of 12.30% — decent returns on equity
Net margin of 18.86% shows strong profitability
Generating 243.29M in free cash flow
P/E of 14.07 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 3.70%
Growth
Revenue Growth (5Y)
4.80%
Revenue (1Y)1.10%
Earnings (1Y)2.52%
FCF Growth (3Y)4.70%
Quality
Return on Equity
12.30%
ROIC8.77%
Net Margin18.86%
Op. Margin29.60%
Safety
Debt / Equity
0.57
Current Ratio4.20
Interest Coverage7.07
Valuation
P/E Ratio
14.07
P/B Ratio1.65
EV/EBITDA11.77
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 1.10% | Revenue Growth (3Y) | 0.44% |
| Earnings Growth (1Y) | 2.52% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 4.80% | Earnings Growth (5Y) | 6.84% |
| Profitability | |||
| Revenue (TTM) | 1.14B | Net Income (TTM) | 214.61M |
| ROE | 12.30% | ROA | 6.31% |
| Gross Margin | 55.76% | Operating Margin | 29.60% |
| Net Margin | 18.86% | Free Cash Flow (TTM) | 243.29M |
| ROIC | 8.77% | FCF Growth (3Y) | 4.70% |
| Safety | |||
| Debt / Equity | 0.57 | Current Ratio | 4.20 |
| Interest Coverage | 7.07 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 14.07 | P/B Ratio | 1.65 |
| P/S Ratio | 2.65 | PEG Ratio | 7.62 |
| EV/EBITDA | 11.77 | Dividend Yield | 0.00% |
| Market Cap | 3.02B | Enterprise Value | 3.97B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.14B | 1.13B | 1.13B | 1.09B | 943.37M |
| Net Income | 214.61M | 209.34M | -82.31M | 205.38M | 164.68M |
| EPS (Diluted) | 4.29 | 4.17 | -1.65 | 4.04 | 3.25 |
| Gross Profit | 634.46M | 624.45M | 625.29M | 620.65M | 547.47M |
| Operating Income | 336.78M | 342.43M | -22.42M | 329.92M | 297.40M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 3.40B | 3.32B | 3.35B | 3.67B | 3.43B |
| Total Liabilities | 1.57B | 1.66B | 1.91B | 2.09B | 2.07B |
| Shareholders' Equity | 1.83B | 1.66B | 1.45B | 1.58B | 1.36B |
| Total Debt | 1.04B | 1.14B | 1.37B | 1.51B | 1.51B |
| Cash & Equivalents | 97.88M | 46.47M | 58.49M | 27.19M | 32.30M |
| Current Assets | 448.33M | 375.04M | 391.74M | 293.27M | 269.84M |
| Current Liabilities | 106.62M | 117.05M | 160.72M | 143.42M | 122.14M |